|
Volumn 20, Issue 3, 2009, Pages 401-402
|
Adherence with adjuvant hormonal therapy for breast cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANASTROZOLE;
AROMATASE INHIBITOR;
TAMOXIFEN;
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER HORMONE THERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG TOLERABILITY;
EDITORIAL;
HUMAN;
LONG TERM CARE;
PATIENT ATTITUDE;
PATIENT COMPLIANCE;
PRESCRIPTION;
PRIORITY JOURNAL;
RECOMMENDED DRUG DOSE;
TREATMENT DURATION;
ANTINEOPLASTIC AGENTS, HORMONAL;
AROMATASE INHIBITORS;
BREAST NEOPLASMS;
FEMALE;
HUMANS;
PATIENT COMPLIANCE;
TAMOXIFEN;
|
EID: 61649109019
PISSN: 09237534
EISSN: 15698041
Source Type: Journal
DOI: 10.1093/annonc/mdp039 Document Type: Editorial |
Times cited : (26)
|
References (7)
|